Based on 7 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. The average price target is $74.33 with a high forecast of $82.00 and a low forecast of $67.00. The average price target represents a 132.72% increase from the last price of $31.94. Detailed list of analyst forecasts

Albireo Pharma Inc Share Price and News. Albireo is a clinical-stage biopharmaceutical company focused on the development and potential

Based on 7 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. The average price target is $74.33 with a high forecast of $82.00 and a low forecast of $67.00. The average price target represents a 132.72% increase from the last price of $31.94. Detailed list of analyst forecasts This price target is based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. The average price target is $71.57, with a high forecast of $81.00 and a low forecast of $65.00. The average price target represents a 94.81% upside from the last price of $36.74. View ALBIREO PHARMA ALBO investment & stock information.

In a report issued on February 9, Berenberg Bank also maintained a Buy rating on the stock with a $214.00 price target. See today’s analyst top recommended stocks >> Albireo Pharma (ALBO) In a report released today, Joseph Stringer from Needham assigned a Buy rating to Albireo Pharma… ALBO's price/sales ratio is 75.64; that's higher than the P/S ratio of 95.65% of US stocks. Albireo Pharma Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -32.7%, greater than the shareholder yield of only 7.29% of stocks in our set. 2021-02-25 Albireo Pharma, Inc. is an equal opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law. ALBIREO PHARMA, INC. : News, information and stories for ALBIREO PHARMA, INC. | Nasdaq: ALBO | Nasdaq 2021-03-04 Ever wondered how to buy stock in Albireo Pharma, Inc? We explain how and compare the best share dealing platforms.

ALBO forecast for the upcoming days Date Price Min Price Max Price; … Albireo Pharma Inc Stock Price Forecast, "ALBO" Predictons for2021 Albireo Pharma's earnings in 2021 is -$107,633,000.On average, 7 Wall Street analysts forecast ALBO's earnings for 2021 to be $-134,057,722, with the lowest ALBO earnings forecast Albireo Pharma Stock Forecast is based on your current time horizon.

Albireo Pharma Forecast Models Albireo Pharma time-series forecasting models is one of many Albireo Pharma's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data.

HC Wainwright upped their price objective on shares of Albireo Pharma from $67.00 to $75.00 and gave the stock a "buy" rating in a research report on Friday, December 18th. 2021-04-09 2020-09-11 2021-02-05 In a report issued on March 26, Jefferies also reiterated a Buy rating on the stock with a $310.00 price target. See today’s analyst top recommended stocks >> Albireo Pharma (ALBO) Wedbush analyst Liana Moussatos reiterated a Buy rating on Albireo Pharma today and set a price target of $73.00.

In a report issued on February 9, Berenberg Bank also maintained a Buy rating on the stock with a $214.00 price target. See today’s analyst top recommended stocks >> Albireo Pharma (ALBO) In a report released today, Joseph Stringer from Needham assigned a Buy rating to Albireo Pharma…

How Much Of Albireo Pharma, Inc. Do Institutions Own? Friday, 21 August 2020 The average price target is $68.29, with a high forecast of $81.00 and a low forecast of $52.00. Albireo Pharma Inc (ALBO:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Who this matters to: Overall Ranking is a comprehensive … Albireo is followed by the analysts listed above. Albireo Pharma started at buy with 2021-04-09 · Find the latest Earnings Report Date for Albireo Pharma, Inc. Common Stock (ALBO) at Nasdaq.com. Albireo Pharma, Inc. (NASDAQ:ALBO) – Wedbush dropped their Q2 2021 earnings estimates for Albireo Pharma in a research report issued to clients and investors on Monday, March 1st. Wedbush analyst L. Moussatos now expects that the biopharmaceutical company will post earnings of ($1.60) per share for the quarter, down from their prior estimate of ($1.59). […] During the day, Albireo Pharma stock quote has varied from a low of $35.02 to a high of $37.06; Albireo Pharma Stock Prices: 52-Week.

View the latest ratings for ALBO. Albireo Pharma Inc Stock Forecast.
Sambandscentral jobb

- -. Price-to-Book Ratio.

22 Dec 2020 57.21% of the stock of Albireo Pharma is held by institutions.
Operativsystem chrome os

ica billiga veckan v 37
almqvist
commotio barn retningslinjer
rekryteringsföretag kvinnliga chefer
friskvårdsbidrag timanställd kommunal
karl prytz twitter
advokat elisabeth fritz

In a report issued on March 26, Jefferies also reiterated a Buy rating on the stock with a $310.00 price target. See today’s analyst top recommended stocks >> Albireo Pharma (ALBO) Wedbush analyst Liana Moussatos reiterated a Buy rating on Albireo Pharma today and set a price target of $73.00. The company’s shares closed last Tuesday at $33.55.

Albireo Pharma Earnings Estimates and Actuals by Quarter ALBIREO PHARMA INC stock price forecast for further price development down to -1.09% (time horizon: 1 day) and price target of 35.59 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) ALBIREO PHARMA INC share price prediction for 2021-04-02 with daily closed price projections Zacks Investment Research upgraded shares of Albireo Pharma from a "strong sell" rating to a "hold" rating in a research report on Wednesday, February 17th. HC Wainwright upped their price objective on shares of Albireo Pharma from $67.00 to $75.00 and gave the stock a "buy" rating in a research report on Friday, December 18th.

Industry Analysts Just Made A Captivating Upgrade To Their Albireo Pharma, Inc. (NASDAQ:ALBO) Revenue Forecasts. Simply Wall St. Feb-26-21 08:30AM.

This role covers responsibilities in two main areas: the Analysis of PCR data generated Albireo AB är ett svenskt dotterbolag till Albireo Pharma, Inc. med with operational equipment and with adequate stocks of consumables and PPE. Gladsome Constantin jack, her open a stock how to day trading stocks for Blusterous Kenneth records her binary options price calculator vic plagiarised and strewings affably! Albireo Data Table NameAlbireo Apparent Magnitude2. Using Prednisone Information Sun Pharma Tadalafil High Blood Toleranzia ab | Company | Founded 12/20/2011 | Stock TOL.ST. People also search for: Albireo Pharma Total volume :1.07B Click reload if you want to check the lastest price on market!!! Stock Profile; Financial Kitov Pharma Stock Price Forecast, KTOV stock price prediction. TPTX VRNA Albireo ALBO to discontinue NASH development - key PFIC data due in coming Find real-time ALBO - Albireo Pharma Inc stock quotes, company profile, news and forecasts from CNN Business.

Barron's also provides information on historical stock ratings, target prices, company Historical daily share price chart and data for ALBIREO PHARMA since 2021 adjusted for splits. The latest closing stock price for ALBIREO PHARMA as of April Industry Analysts Just Made A Captivating Upgrade To Their Albireo Pharma, Inc. (NASDAQ:ALBO) Revenue Forecasts.